Dr. Scott Rocklage is the primary managing partner for 5AM Ventures. Not only is he a healthcare manager, he is also a biopharmaceutical expert. It all began at The University of California Berkeley where he got his bachelors in Chemistry and ended at Massachusetts Institute of Technology where he received his Ph.D. in Chemistry.
Dr. Rocklage now has over 20 years of experience and an extended amount of credibility to back that up. He has been a board member for WaveRx and VBI Vaccines, a board director for Novira Therapeutucs, Pulmatrix, Rennovia and Epirus Biopharmaceuticals, and a board chairman for Relypsa, Achaogen, and Semprus BioSciences.
He currently has 8 investments throughout 4 companies worth over $189 million dollars invested in Novira, Achaogen, Pulmatrix, and Rennovia. Besides the business aspect of things, Dr. Rocklage also has 20 years worth of experience in the health care field.
He was apart of getting three applications passed by FDA for the creation of new drugs and six candidates for trial runs. Mr. and Mrs. Rocklage recently donated $250,000 dollars to the rebuilding process of a nano chemistry and nano technology lab space.
Dr. Scott Rocklage joined 5AM Ventures in 2003 as a venture partner then became the managing partner in 2004. 5AM Ventures specializes in startup companies by investing or buying stakes in a company to in turn hopefully receive advertising space. Headquarters is located in Paris, France. 5AM Ventures is made up of professionals as well as investors with a passion for customer sector companies.